Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Rasmussen, Erik
1523  Ergebnisse:
Personensuche X
?
1

Handbook of research on business model innovation through d..:

Rasmussen, Erik ; Peterson, Nicolaj , 2023
Link: http://services.igi-glob..
 
?
2

Hypermedia-based software architecture enables Test-Driven ..:

Post, Andrew R ; Ho, Nancy ; Rasmussen, Erik...
JAMIA Open.  6 (2023)  4 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
3

Digital entrepreneur's platformication and rapid internatio..:

Petersen, Nicolaj Hannesbo ; Rasmussen, Erik
Small Enterprise Research.  31 (2023)  1 - p. 18-38 , 2023
Link: https://doi.org/10.1080/..
 
?
4

Appropriateness of referrals from primary care for lumbar M..:

Krogh, Susanne Brogaard ; Jensen, Tue Secher ; Rolving, Nanna...
Chiropractic & Manual Therapies.  30 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
5

Phase 1 Expansion Cohort of Ramucirumab Plus Pembrolizumab ..:

Herbst, Roy S. ; Arkenau, Hendrik Tobias ; Bendell, Johanna...
Journal of Thoracic Oncology.  16 (2021)  2 - p. 289-298 , 2021
Link: https://doi.org/10.1016/..
 
?
6

Real-world treatment patterns and outcomes of abemaciclib f..:

Cuyun Carter, Gebra ; Sheffield, Kristin M. ; Gossai, Anala...
Current Medical Research and Opinion.  37 (2021)  7 - p. 1179-1187 , 2021
Link: https://doi.org/10.1080/..
 
?
7

Categorisation of lumbar spine MRI referrals in Denmark as ..:

Krogh, Susanne Brogaard ; Jensen, Tue Secher ; Rolving, Nanna...
Chiropractic & Manual Therapies.  29 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
8

Safety and efficacy of AMG 820, an anti-colony-stimulating ..:

Razak, Albiruni RA ; Cleary, James M ; Moreno, Victor...
Journal for ImmunoTherapy of Cancer.  8 (2020)  2 - p. e001006 , 2020
Link: https://doi.org/10.1136/..
 
?
9

Phase 1 study of the anti-BCMA antibody-drug conjugate AMG ..:

Lee, Hans C. ; Raje, Noopur S. ; Landgren, Ola...
Leukemia.  35 (2020)  1 - p. 255-258 , 2020
Link: https://doi.org/10.1038/..
 
?
10

Phase 1b study of the MDM2 inhibitor AMG 232 with or withou..:

Erba, Harry P. ; Becker, Pamela S. ; Shami, Paul J....
Blood Advances.  3 (2019)  13 - p. 1939-1949 , 2019
Link: https://doi.org/10.1182/..
 
?
11

Safety, tolerability, and pharmacokinetics of anti-EGFRvIII..:

Rosenthal, Mark ; Curry, Richard ; Reardon, David A....
Cancer Chemotherapy and Pharmacology.  84 (2019)  2 - p. 327-336 , 2019
Link: https://doi.org/10.1007/..
 
?
12

ATIM-49 (LTBK-01). AMG 596, A NOVEL ANTI-EGFRVIII BISPECIFI..:

Rosenthal, Mark A ; Balana, Carmen ; van Linde, Myra E...
Neuro-Oncology.  21 (2019)  Supplement_6 - p. vi283-vi283 , 2019
Link: https://doi.org/10.1093/..
 
?
13

Phase 1 study of the MDM2 inhibitor AMG 232 in patients wit..:

Gluck, W. Larry ; Gounder, Mrinal M. ; Frank, Richard...
Investigational New Drugs.  38 (2019)  3 - p. 831-843 , 2019
Link: https://doi.org/10.1007/..
 
?
14

First-in-human study to assess safety, tolerability, pharma..:

Massard, Christophe ; Soria, Jean-Charles ; Krauss, Jürgen...
Cancer Chemotherapy and Pharmacology.  83 (2019)  6 - p. 1057-1063 , 2019
Link: https://doi.org/10.1007/..
 
?
15

The anti-BCMA Bispecific T-cell Engager (BiTE®) Molecule AM..:

Einsele, Hermann ; Duell, Johannes ; Zugmaier, Gerhard...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e18-e19 , 2019
Link: https://doi.org/10.1016/..
 
1-15